AB vs BGC

The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score, raising concerns about bankruptcy risk assessment. Despite a high dividend yield of 8.73%, the payout ratio of 111.92% is unsustainable, supported by negative profit margin and declining revenue. Valuation appears stretched relative to intrinsic metrics, with the stock trading at $38.96 versus a Graham Number of $29.35 and intrinsic value of $20.72. Negative insider sentiment, deteriorating growth trends, and weak technicals further reinforce a bearish outlook.

BGC has a stable Piotroski F-Score of 6/9, indicating moderate financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock shows strong revenue and earnings growth, with a high ROE of 14.56%, yet trades at a premium valuation (P/E 27.84 vs sector avg 22.39) despite a low Graham Number of $3.82, suggesting overvaluation on a defensive basis. While analyst consensus is strong_buy, insider selling worth $5.82M and a bearish technical trend signal caution. The fair value estimate is adjusted above the Graham Number due to growth metrics but tempered by leverage and weak technicals.